RUNX1 and leukemia: After detecting the genomic flanking sequences of the breakpoint in the leukemia cells from the patients with ETV6‐RUNX1‐positive ALL who relapsed by the Sanger method, the results indicated that all relapse samples conserved the ETV6‐RUNX1 fusion gene and that the sequences were identical to that of the diagnosis samples.